MAPT and Alzheimer disease: Significant progress has been made in developing a number of PET imaging tracers for distinctive protein aggregates of Alzheimer’s disease (AD), i.e., β-amyloid (Aβ) plaques [1] and hyperphosphorylated tau [2], which are increasingly used in clinical applications.